An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of inducible nitric oxide synthase and cyclo-oxygenase-2

European Journal of Pharmacology

Volumn 397, Issue 1, 2000, Pages 207-217

  Rioja, Inmaculada ^a   Ubeda, Amalia ^a   Terencio, M Carmen ^a   Guillén, Isabel ^a   Riguera, Ricardo ^b   Quintela, José M ^c   Peinador, Carlos ^c   González, Liliana M ^c   Alcaraz, M José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Air pouch, mouse; Carrageenan paw oedema; Ditriazines; Eicosanoid; Macrophage; Neutrophil; Nitric oxide (NO)

Indexed keywords

4,10 DICHLOROPYRIDO[5,6:4,5]THIENO[3,2 D':3,2 D] 1,2,3 DITRIAZINE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; LEUKOTRIENE B4; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGRANULATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE FUNCTION; NEUTROPHIL; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PLATELETS; CARRAGEENAN; CELL-FREE SYSTEM; CHEMILUMINESCENT MEASUREMENTS; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FEMALE; HINDLIMB; HUMANS; INFLAMMATION; ISOENZYMES; LEUKOCYTES; LEUKOTRIENE B4; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICROSOMES; NEUTROPHIL ACTIVATION; NEUTROPHILS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PANCREATIC ELASTASE; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THROMBOXANE B2; TRIAZINES; ZYMOSAN;

EID: 0034717221     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00243-0     Document Type: Article

References (47)

1. Abramson S.B., Leszczynska-Piziak J., Clancy R.M., Philips M., Weissmann G. Inhibition of neutrophil function by aspirin-like drugs (NSAIDS): requirement for assembly of heterotrimeric G proteins in bilayer phospholipid. Biochem. Pharmacol. 47:1994;563-572.
2. Alving K., Weitzberg E., Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 6:1993;1368-1370.
3. Betts W.H. Detecting oxy radicals by chemiluminescence. Greenwald R.A. Handbook of Methods for Oxygen Radical Research. 1985;197-201 CRC Press, Boca Raton, FL.
4. 2 synthase inhibitor and receptor antagonist in vitro. Br. J. Pharmacol. 110:1993;1600-1606.
5. Bustos G., Ferrándiz M.L., Sanz M.J., Payá M., Alcaraz M.J. A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;298-304.
6. 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7708-7712.
7. Cobb J.P., Danner R.L. Nitric oxide and septic shock. JAMA. 275:1996;1192-1196.
8. Demiryurek A.T., Cakici I., Kanzik I. Peroxynitrite: a putative cytotoxin. Pharmacol. Toxicol. 82:1998;113-117.
9. Di Rosa M., Radomski M., Carnuccio R., Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172:1990;1246-1252.
10. Edwards J.C.W., Sedgwick A.D., Willoughby D.A. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134:1981;147-156.
11. 2 with anti-inflammatory activity. J. Pharmacol. Exp. Ther. 282:1997;123-131.
12. 2 associated with rabbit polymorphonuclear leukocyte granules. J. Lipid Res. 15:1974;380-388.
13. Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem. Pharmacol. 53:1997;1389-1395.
14. Gross S.S., Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267:1992;25722-25729.
15. Guerrera F., Salerno L., Sarva M.C., Siracusa M.A. Synthesis and antifungal activity of pyrido[3′,2′:4,5]thieno[3,2-d]1,2,3-triazine derivatives. Farmaco. 48:1993;1725-1733.
16. Henderson W.R. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:1994;684-697.
17. Ianaro A., O'Donnell C.A., Di Rosa M., Liew F.Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology. 82:1994;370-375.
18. Iuvone T., Carnuccio R., Di Rosa M. Modulation of granuloma formation by endogenous nitric oxide. Eur. J. Pharmacol. 265:1994;89-92.
19. Kang R.Y., Freire Moar J., Sigal E., Chu C.Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol. 35:1996;711-718.
20. Kankaanranta H., Moilanen E., Vapaatalo H. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;685-691.
21. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:1994;9-12.
22. Kröncke K.-D., Fehsel K., Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection - how, why, when and where? Nitric Oxide: Biol. Chem. 1:1997;107-120.
23. Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New England J. Med. 323:1990;645-655.
24. Lo C.J., Cryer H.G., Fu M., Lo F.R. Regulation of macrophage eicosanoid generation is dependent on nuclear factor kappaB. J. Trauma. 45:1998;19-23.
25. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
26. Marcinkiewicz J., Grabowska A., Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:1995;947-951.
27. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:1993;11-16.
28. Mitchell J.A., Sheng H., Förstermann U., Murad F. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle. Br. J. Pharmacol. 104:1991;289-291.
29. Moroney M.A., Alcaraz M.J., Forder R.A., Carey F., Hoult J.R.S. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J. Pharm. Pharmacol. 40:1988;787-792.
30. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., Bours V. Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem. 378:1997;1237-1245.
31. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 271:1996;13422-13429.
32. Posadas I., Terencio M.C., Guillén I., Ferrándiz M.L., Coloma J., Payá M., Alcaraz M.J. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:2000;98-106.
33. Quintela J.M., Peinador C., Veiga C., Gonzalez L., Botana L.M., Alfonso A., Riguera R. Synthesis and antiallergic activity of pyridothienopyrimidines. Bioorg. Med. Chem. 6:1998;1911-1925.
34. Quintela J.M., Peinador C., González L.M., Rioja I., Terencio M.C., Ubeda A., Alcaraz M.J., Riguera R. Synthesis and pharmacological evaluation of some 8-cyanopyrido[3′,2′:4,5]thieno[3,2-d] triazine derivatives as inhibitors of nitric oxide and eicosanoid biosynthesis. J. Med. Chem. 42:1999;4720-4724.
35. Remick D.G., Villarete L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J. Leukocyte Biol. 59:1996;471-475.
36. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7240-7244.
37. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needleman P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96:1995;301-308.
38. Salvemini D., Wang Z.-Q., Bourdon D.M., Stern M.K., Currie M.G., Manning P.T. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur. J. Pharmacol. 303:1996;217-220.
39. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12013-12017.
40. Smith J.A. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56:1994;672-686.
41. Sugishita E., Amagaya S., Ogihara Y. Anti-inflammatory testing methods: comparative evaluation of mice and rats. J. Pharmacobio-Dyn. 4:1981;565-575.
42. Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132:1983;345-352.
43. Tateson J.E., Randall R.W., Reynolds C.H., Jackson W.P., Bhattacherjee P., Salmon J.A., Garland L.G. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br. J. Pharmacol. 94:1988;528-539.
44. Thomas P.D., Mao G.D., Rabinovitch A., Poznansky M.J. Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). Biochem. Pharmacol. 45:1993;241-251.
45. Vane J.R., Mitchell J.A., Appleton I., Tomlison A., Bishop-Bailey D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A. 91:1994;2046-2050.
46. Wagner G., Leistner S., Viewer H., Krasselt U., Prantz J. Synthese neuer pyrido[3′,2′:4,5]thieno[3,2-d]-1,2,3-triazin-derivate als antianaphylaktika. Pharmazie. 48:1993;514-518.
47. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.